ARS/Rescue Rooter is a Proud Partner of St. Jude Children’s Research Hospital
ARS/Rescue Rooter is proud to support St. Jude Children’s Research Hospital and its mission: Finding cures. Saving children®. Since 2018, ARS has raised almost $9 million to support St. Jude as they pioneer cures for childhood cancer and other life-threatening diseases. Breakthroughs in research and treatment have helped St. Jude advance the overall childhood cancer survival rate from 20% to 80% since the hospital opened its doors in 1962. Through branch donations, sponsorships, direct mail campaigns, nationwide sales events, and employee payroll giving, our network of more than 70 branches and 6,500 employees have helped St. Jude improve the quality of care for children everywhere.
Please join us in supporting St. Jude by donating directly here.
CHRO Chris Snow and CFO Christie Grumbos present our 2024 donation to ALSAC representatives.
St. Jude Patient of the Month: Hazel
Hazel's Story
Hazel is a little girl who is a big fan of rainbows, unicorns, make-up, and dress up. She also likes to color, create crafts, and help her dad cook.
“She’s up and down all the time,” said her dad, David. “If she’s feeling energy, she will be bouncing around the house, jumping on the trampoline, and climbing on stuff.”
A year earlier in 2022, when Hazel was just two, her parents, David and Hannah, noticed she was having balance issues. A visit to a local hospital near their home in Kentucky revealed a brain tumor. Thirty-six hours later, Hazel had brain surgery.
When the couple left Hazel in the pre-op room, they were overwhelmed with emotions.
“We both had the deepest feelings of dread. We didn’t know what would happen or who would be coming out. A few long hours later, Hazel came out, still as feisty as ever,” David recalled.
Doctors were able to remove the tumor, but Hazel needed further treatment for the malignant tumor called medulloblastoma. Hazel was referred to St. Jude Children’s Research Hospital®.
At St. Jude, doctors looked at the genetic markers of Hazel’s tumor to determine the course of treatment. Hazel received chemotherapy and then proton radiation. She returned home in September 2023. She goes back to the research hospital every three months for checkups, David said.
David said he knew about St. Jude prior to his daughter’s diagnosis but wasn’t sure what to really expect.
“Everyone there went above and beyond to do their very best for us – from doctors to the nurses to those in the cafeteria,” he said. “Everyone we interacted with, they all really cared.”